In 62 immunological measures, 57 differed between wild and laboratory mice, researchers found

Goal is vaccine that targets inflammation in joints

The nanovaccine consists of tumor antigens—tumor proteins that can be recognized by the immune system—inside a synthetic polymer nanoparticle

A person doesn't have to get sick to catch a virus. Researchers hope to catch viruses for detection and vaccinations by understanding their sticky outer layers

In the first study of functional immunity to Campylobacter jejuni in the chicken, researchers have shown that antibody production plays a role, albeit limited, in the clearance of intestinal infection

Most vaccines targeting tumor-associated antigens have had limited success so far in producing therapeutic effects against most cancers due to poor immunogenicity

Results from Penn-Duke-NIH team highlight the promise of mRNA-based vaccines and therapies

The vaccine is the first to prevent infection from one of the most lethal known pathogens, and the findings add weight to early trial results published last year

There is no vaccine currently available for salmonella poisoning

"Our paper shows that it’s possible to attenuate RSV without losing any immunogenicity," says senior author